LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Real-Time Apneic Screening Device

By Biotechdaily staff writers
Posted on 12 Jan 2007
A small, easy-to-use, and unobtrusive device allows screening for apneic events in persons who may be suspected of having obstructive sleep apnea (OSA).

The battery-powered RUSleeping real time screening (RTS) device consists of a base unit and a nasal cannula. Respiratory airflow pressure is sensed via the cannula and the device starts to record apneic events. When breathing decreases by 50% or more for 10 seconds or longer, it is considered an apneic event and is recorded on the liquid crystal display (LCD) readout. The device is convenient to operate and can be re-used. No accessory equipment, software, or electrical outlet is needed.

Based upon a patient's at-home overnight score, physicians can interpret if the patient is a likely candidate for an immediate polysomnogram (PSG). Sleep lab physicians can provide the RUSleeping RTS to patients to pre-screen at home for OSA before the patient is seen for an in-lab PSG. By being presented with objective data regarding their apneic events, patients may more readily accept the need for a complete PSG and consequent treatment, if needed. The RUSleeping RTS is manufactured by Respironics (Murrysville, PA, USA).

"The RUSleeping RTS device is much less cumbersome and expensive than many other screening devices. It is a quick and simple tool for busy clinicians who have patients presenting with subjective symptoms of OSA,” said Respironics product manager Rick Herrle. "This may help bring patients one step closer to diagnosis and treatment, which is what good patient outcomes are all about.”



Related Links:
Respironics

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Neonatal Heel Incision Device
Tenderfoot
Gold Member
Pre- Eclampsia Control
Acusera Pre-Eclampsia Control
New
Microbiology Laboratory Automation Solution
BD Kiestra™ ReadA+BarcodA

Latest BioResearch News

D-Serine May Predict Immune Checkpoint Therapy Resistance in Gastric Cancer
12 Jan 2007  |   BioResearch

New Genetic Cause Identified for Neurodevelopmental Disorder
12 Jan 2007  |   BioResearch

New Genetic Discovery Could Support Precision Diabetes Care
12 Jan 2007  |   BioResearch